Study of LL-BMT1 in Patients With Elevated Intraocular Pressure

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

February 16, 2021

Study Completion Date

February 16, 2021

Conditions
Primary Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

LL-BMT1

Drug-printed contact lens in both eyes

Trial Locations (1)

92663

Eye Research Foundatoin, Newport Beach

Sponsors
All Listed Sponsors
lead

MediPrint Ophthalmics, Inc.

INDUSTRY

NCT04747808 - Study of LL-BMT1 in Patients With Elevated Intraocular Pressure | Biotech Hunter | Biotech Hunter